Buy or sell CTRL-Labs stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
CTRL-Labs Stock
CTRL-Labs dedicates itself to answering the biggest questions in computing, neuroscience, and design so creators can dream.
About CTRL-Labs Stock
CTRL-Labs dedicates itself to answering the biggest questions in computing, neuroscience, and design so creators can dream. Their work to build a transformative brain-machine interface spans research and challenges at the intersection of computational neuroscience, statistics, machine learning, biophysics, hardware, and human-computer interaction.
Funding History
| September 2017 | $11.0M |
|---|---|
| May 2018 | $28.0M |
Management
Lead Scientist
Jeffrey Seely
Director of R&D
Adam Berenzweig
CEO and Co-Founder
Thomas Reardon
Research Engineer
Adam Al-Natsheh
Chief Operating Officer
Ben Jones
Software Architect
Attila Maczak
Co-Founder
Timothy Machado
Chief Science Officer
Patrick Kaifosh
Press
TechCrunch - Jun, 27 2019
Forbes - Mar, 22 2019
TechCrunch - Dec, 10 2018
TechCrunch - Nov, 1 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from CTRL-Labs or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
